STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #955 by analyst upside · 2026-08-13
ALHC
Alignment Healthcare, Inc.
Healthcare · Market Cap $3B · P/E 71.2x
ANALYST PRICE TARGET
+78.1%
implied upside to consensus target
Current Price $13.52
Consensus Target $24.08
Bull Target $30.0
Bear Target $16.0
Analysts Covering 13
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
8
Hold
2
Sell
0
52-Week Low $13.05
52-Week High $25.12
YTD Return -33.1%
FUNDAMENTALS
Market Cap $3B
P/E Ratio (TTM) 71.2x
Forward P/E 18.0x
EPS (TTM) $0.19
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $4.6B
Profit Margin 0.9%
52-WEEK RANGE
52-Week Low $13.05
52-Week High $25.12
Current Price $13.52
Bear Target $16.0
Bull Target $30.0
● Now $13.52 ● Target $24.08
TRADING DATA
Avg Volume 6.2M
YTD Return -33.1%
Analyst Count 13
Consensus Buy
Upside to Target +78.1%
Last Updated 2026-08-13

ANALYST SUMMARY

Alignment Healthcare, Inc. (ALHC) is currently trading at $13.52 with a Wall Street consensus price target of $24.08, implying potential upside of 78.1% over the next 12 months. 13 analysts currently cover ALHC, with a consensus rating of Buy - 85% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $30.0, while the most cautious has a target of $16.0.

ALHC operates in the Healthcare sector with a market capitalisation of $3B. The stock is down 33.1% year-to-date and is currently trading near the lower end of its 52-week range of $13.05 – $25.12.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ALHC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-05-26 Building track record
UBS - Reiterated
Neutral → Neutral 2026-05-01 33% win rate (6 calls)
Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-05-01 Building track record
JP Morgan - Reiterated
Overweight → Overweight 2026-02-05 43% win rate (7 calls)
TD Cowen - Reiterated
Buy → Buy 2026-01-16 Building track record
UBS - Reiterated
Neutral → Neutral 2026-01-14 33% win rate (6 calls)
Piper Sandler - Reiterated
Overweight → Overweight 2026-01-06 14% win rate (7 calls)
JP Morgan - Reiterated
Overweight → Overweight 2025-12-17 43% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
51
out of 100
Coverage depth
20/30
Consensus clarity
9/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →